Taikang Asset Management (Hong Kong) CO LTD Legend Biotech Corp Transaction History

Taikang Asset Management (Hong Kong) CO LTD

$641 Million
Q2 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 09, 2021	SELL	$25.8 - $32.39 $6.81 Million - $8.55 Million	-263,903 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$27.5 - $39.61 $380,572 - $548,162	-13,839 Reduced 4.98%	263,903 $8.15 Million
Q2 2020 Aug 12, 2020	BUY	$36.1 - $42.56 $10 Million - $11.8 Million	277,742 New	277,742 $11.8 Million

Others Institutions Holding LEGN

# of Institutions

204

Shares Held

74.3M

Call Options Held

374K

Put Options Held

387K

Price T Rowe Associates Inc Baltimore, MD

11.5M
Shares

$513 Million
0.06% of portfolio
Ra Capital Management, L.P. Boston, MA

7.51M
Shares

$335 Million
5.01% of portfolio
Hhlr Advisors, Ltd. Grand Cayman, E9

6.64M
Shares

$296 Million
7.6% of portfolio
Black Rock Inc. New York, NY

5.72M
Shares

$255 Million
0.01% of portfolio
Westfield Capital Management CO LP Boston, MA

4.77M
Shares

$213 Million
1.06% of portfolio

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $7.47B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Taikang Asset Management (Hong Kong) CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Taikang Asset Management (Hong Kong) CO LTD with notifications on news.

Account